2008年全球上市的新活性物质评述  

Comments on new active substances coming into the world market in 2008

作　　者：陈玲[1] 许红[1] 邹栩[1] 

机构地区：[1]中国药科大学,南京210009

出　　处：《中国新药杂志》2009年第11期969-975,987,共8页Chinese Journal of New Drugs

基　　金：江苏省科技厅软科学研究计划(BR2008097)

摘　　要：与2007年全球上市新药相比,2008年全球制药企业重整旗鼓,共推出了31个新活性物质。本文将这31种全球首次上市的新药,按照药效分类,对其治疗用途、适应证等信息逐一进行简要介绍,以期为我国新药研发提供参考依据。In comparison with the landscape of new drugs in 2007, the productivity of pharmaceutical industry rallies in 2008, and a total of 31 new active substances come into the world market. In this paper, the 31 new substances were briefly introduced, including their efficacy and indication, to offer some advices to the pharmaceutical R＆D in China.

关 键 词：新活性物质 上市新药 新化合物实体 抗凝药 遗传性血管性水肿(HAE) ITP 

分 类 号：R95[医药卫生—药学]